Joseph Michael Fitzgerald
CIK 1484186 · EVP & Group Pres, Cardiology · last filed 2026-08-03
Joseph Michael Fitzgerald is an EVP & Group Pres, Cardiology who has filed 141 SEC Form 4 insider transactions across 1 company since 2010. The most recent filing, for BSX, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$78.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.9M across reported positions. 136 SEC filings were submitted jointly with BOSTON SCIENTIFIC CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BSX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BSX | EVP & Group Pres, Cardiology | 219,141 | $45.05 | $9.87M | -$78.51M | 129 | 2026-08-03 |
Recent Filings
141 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-03 | BSX | Disc (I) | +64,198 | $3.00M | EDGAR |
| 2026-02-18 | BSX | Mixed | +44,015 | -$2.76M | EDGAR |
| 2026-02-17 | BSX | Mixed | +1,850 | -$119.5K | EDGAR |
| 2025-11-14 | BSX | Gift (G) | −10,300 | $0 | EDGAR |
| 2025-11-04 | BSX | Mixed | — | -$3.67M | EDGAR |
| 2025-11-03 | BSX | Notice (144) | −50,000 | -$4.97M | EDGAR |
| 2025-10-01 | BSX | Notice (144) | −50,000 | -$4.92M | EDGAR |
| 2025-10-01 | BSX | Mixed | — | -$3.62M | EDGAR |
| 2025-09-03 | BSX | Mixed | — | -$3.96M | EDGAR |
| 2025-09-02 | BSX | Notice (144) | −50,000 | -$5.27M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.